
CDK5 Blocker Has Remarkable Effect on Alzheimer’s
A new peptide may hold potential as an Alzheimer’s treatment
Researchers say the CDK5 Blocker peptide blocks a hyperactive brain enzyme that contributes to the neurodegeneration seen in Alzheimer’s and other diseases.